Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLVR System in advanced upper lobe predominant emphysema
NCT00716053Phase 3Withdrawn
- Sponsor
- Aeris Therapeutics
- Start
- Dec 2008
- Primary completion
- Dec 2009
01
Overview
A Phase 3 trial of AeriSeal in emphysema, sponsored by Aeris Therapeutics. Planned start Dec 2008; status: withdrawn.
02
Drugs
AeriSeal
03
Conditions
emphysema
Beyond the preview
Go deeper on NCT00716053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00716053.